Pharmacy coupons for prescription drugs can seem like a great deal, offering potential savings. However, their impact on costs can be complex, especially for those with insurance. A study published in the Journal of the American Medical Association on April 6 found that while drug manufacturers continue to offer coupons, their usage among commercially insured patients has dropped significantly, from 54.6% in 2017 to just 2.5% in 2024 for certain obesity drugs. This decline reflects rising drug prices and insurers' reluctance to cover these medications. For uninsured patients, coupons can provide substantial savings, particularly through initiatives like TrumpRx, which aggregates coupon offers. However, for those with insurance, the decision to use coupons depends on various factors, including whether the drug is covered and anticipated medical costs for the year. Insurers often implement copay accumulator and maximizer programs that can negate the benefits of using coupons, leading to higher out-of-pocket expenses in the long run. Additionally, beneficiaries of Medicare and Medicaid cannot utilize these coupons due to federal regulations. Understanding these nuances is crucial for consumers to make informed decisions at the pharmacy counter.